US Patent 9266860 Aryl-substituted imidazoles
Patent 9266860 was granted and assigned to St. Jude Children's Research Hospital on February, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+436 characters)
Article
Patent abstract
The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09266860 Aryl-substituted imidazoles US Patent 9266860 Aryl-substituted imidazoles
Infobox
Patent Number
0926686000
Patent Number
926686000
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092668600
Date of Patent
February 23, 2016
0Patent Application Number
138764650
Date Filed
September 30, 2011
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092668600
Date of Patent
February 23, 2016
0Patent Application Number
138764650
Date Filed
September 30, 2011
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09266860 Aryl-substituted imidazoles
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09266860
Date of patent
February 23, 2016
Patent application number
13876465
Date Filed
September 30, 2011
Patent primary examiner
Find more entities like US Patent 9266860 Aryl-substituted imidazoles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
